Figure 4.
Figure 4. Pie chart showing that only about 18% of patients with chronic myelogenous leukemia (CML) can in fact be cured by allogeneic stem cell transploant (allo-SCT).

Pie chart showing that only about 18% of patients with chronic myelogenous leukemia (CML) can in fact be cured by allogeneic stem cell transploant (allo-SCT).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal